Search

everythinglearnresearchcommunity

for

Search:↓

Ultrasonography in dermatology improves diagnosis and treatment of skin conditions.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Menopause affects hair and skin; more research needed for treatment.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The study found that mouse sweat glands develop before birth, mature after birth, and have specific keratin patterns.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.